RecallDepth
Class II Terminated

Fluoxetine Capsules USP, 20 mg, packaged in a) 100-count bottles (NDC 50111-648-01), b) 500-count bottles (NDC 50111-648-02), c) 1000-count bottles (NDC 50111-648-03), and d) 2000-count bottles (NDC 50111-648-44), Rx only, Manufactured in Poland By: Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960.

This recall has been terminated (originally issued May 7, 2014).

Company
Teva Pharmaceuticals Usa
Recall Initiated
February 12, 2014
Posted
May 7, 2014
Recall Number
D-1280-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
257904 bottles
Firm Location
Horsham, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot #: a) 6A211150, 6A211151, 6A211152, 6A211153, 6A211154, Exp 11/15; 6A212083, 6A212084, 6A212085, 6A212086, Exp 12/15; b) 6A211143, 6A211145, 6A211146, 6A211147, Exp 11/15; c) 6A209116, 6A209117, 6A209118, 6A209119, 6A209120, Exp 09/15; 6A211139, 6A211140, 6A211141, Exp 11/15; 6A212087, Exp 12/15; d) 6A209124, Exp 09/15; 6A211144, 6A211148, 6A211149, Exp 11/15

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls